Direct CCL4 Inhibition Modulates Gut Microbiota, Reduces Circulating Trimethylamine N-Oxide, and Improves Glucose and Lipid Metabolism in High-Fat-Diet-Induced Diabetes Mellitus

Ting-Ting Chang1 Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan;2 Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan;3 School of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanView further author information

Jaw-Wen Chen1 Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan;2 Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan;3 School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan;4 Healthcare and Services Center, Taipei Veterans General Hospital, Taipei, Taiwan;5 Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan;6 Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, TaiwanCorrespondence[email protected] [email protected]
View further author information

Direct CCL4 Inhibition Modulates Gut Microbiota, Reduces Circulating Trimethylamine N-Oxide, and Improves Glucose and Lipid Metabolism in High-Fat-Diet-Induced Diabetes Mellitus

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Direct CCL4 Inhibition Modulates Gut Microbiota, Reduces Circulating Trimethylamine N-Oxide, and Improves Glucose and Lipid Metabolism in High-Fat-Diet-Induced Diabetes Mellitus

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date